Zyvox (linezolid), a potent new antibiotic for certain resistant gram-positive infections

The FDA just approved Zyvox (linezolid), a potent new antibiotic for certain resistant gram-positive infections.

Zyvox is the first in a new class...oxazolidinones. It works by inhibiting bacterial protein synthesis.

It will be used for certain gram-positive infections...including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote